Eventide Asset Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Eventide Asset Management, LLC
- $4.71 Billion
- Q1 2025
A detailed history of Eventide Asset Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 166,450 shares of ALNY stock, worth $71.6 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
166,450
Previous 240,418
30.77%
Holding current value
$71.6 Million
Previous $56.6 Million
20.55%
% of portfolio
0.95%
Previous 1.08%
Shares
7 transactions
Others Institutions Holding ALNY
# of Institutions
745Shares Held
111MCall Options Held
916KPut Options Held
841K-
Capital World Investors Los Angeles, CA16.7MShares$7.2 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$5.72 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.1 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$3.08 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.9 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $52.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...